Citius Pharmaceuticals, Inc. 13D and 13G filings for Citius Oncology Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-16 4:34 pm Purchase | 2024-08-12 | 13D | Citius Oncology Inc. CTOR | Citius Pharmaceuticals Inc. CTXR | 66,049,615 92.600% | 66,049,615 (New Position) | Filing |